The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs

被引:11
|
作者
Toenders, Wil [1 ]
机构
[1] ToendersdeGroot BV, Maarssen, Netherlands
来源
关键词
generic drugs; international non-proprietary name; pharmacoeconomics; generic name; drug costs; bioequivalence studies;
D O I
10.3389/fphar.2013.00113
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] GENERIC VS BRAND NAME DRUGS FOR THE TREATMENT OF HYPERTENSION
    Dinic, Miriana
    Maillard, Nicolas
    Bouiller, Marc
    Alamartine, Eric
    Mariat, Christophe
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [2] GENERIC VERSUS BRAND NAME DRUGS
    不详
    [J]. RHODE ISLAND MEDICAL JOURNAL, 1974, 57 (01): : 26 - 26
  • [3] Prescription Trends-Brand-name Drugs vs Generic
    Chee, Mark
    Ngooi, Samantha
    Arora, Vineet M.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (10) : 1573 - 1574
  • [4] BRAND VS GENERIC DRUGS - ITS ONLY A MATTER OF NAME
    SIMMONS, HE
    [J]. FDA CONSUMER, 1973, 7 (02) : 4 - 6
  • [5] GENERIC VS BRAND-NAME DRUGS FOR THE TREATMENT OF HYPERTENSION
    Dinic, M.
    Maillard, N.
    Bouiller, M.
    Alamartine, E.
    Mariat, C.
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 : E123 - E123
  • [6] Brand-Name Versus Generic Drugs
    Manning, Richard
    Smith, Richard
    [J]. HEALTH AFFAIRS, 2011, 30 (10) : 2027 - 2027
  • [7] Switching brand name drugs to generic drugs in German general praxis
    Simmenroth-Nayda, A
    Gleiter, CH
    Niebling, W
    Hummers-Pradier, E
    Kochen, MM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S97 - S97
  • [8] Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D
    Dusetzina, Stacie B.
    Sarpatwari, Ameet
    Carrier, Michael A.
    Hansen, Richard A.
    Keating, Nancy L.
    Huskamp, Haiden A.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1605 - 1611
  • [9] Prescription Trends-Brand-name Drugs vs Generic Reply
    Kesselheim, Aaron S.
    Gagne, Joshua J.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (10) : 1574 - 1575
  • [10] UNIFORM APPEARANCE OF GENERIC AND BRAND-NAME DRUGS
    KAHN, BS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (26): : 1492 - 1492